Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Ibodutant

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 522664-63-7, Men-15596, Ibodutant [inn], Men15596, 1h7rsq28bj, 6-methyl-n-[1-[[(2r)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide
    Molecular Formula
    C37H48N4O4S
    Molecular Weight
    644.9  g/mol
    InChI Key
    YQYSVMKCMIUCHY-WJOKGBTCSA-N
    FDA UNII
    1H7RSQ28BJ
    Ibodutant has been used in trials studying the treatment of Irritable Bowel Syndrome and Irritable Bowel Syndrome With Diarrhea.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    6-methyl-N-[1-[[(2R)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide
    2.1.2 InChI
    InChI=1S/C37H48N4O4S/c1-26-9-10-30-23-33(46-32(30)21-26)35(43)40-37(15-5-6-16-37)36(44)39-31(22-27-7-3-2-4-8-27)34(42)38-24-28-11-17-41(18-12-28)25-29-13-19-45-20-14-29/h2-4,7-10,21,23,28-29,31H,5-6,11-20,22,24-25H2,1H3,(H,38,42)(H,39,44)(H,40,43)/t31-/m1/s1
    2.1.3 InChI Key
    YQYSVMKCMIUCHY-WJOKGBTCSA-N
    2.1.4 Canonical SMILES
    CC1=CC2=C(C=C1)C=C(S2)C(=O)NC3(CCCC3)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC5CCN(CC5)CC6CCOCC6
    2.1.5 Isomeric SMILES
    CC1=CC2=C(C=C1)C=C(S2)C(=O)NC3(CCCC3)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)NCC5CCN(CC5)CC6CCOCC6
    2.2 Other Identifiers
    2.2.1 UNII
    1H7RSQ28BJ
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 522664-63-7

    2. Men-15596

    3. Ibodutant [inn]

    4. Men15596

    5. 1h7rsq28bj

    6. 6-methyl-n-[1-[[(2r)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide

    7. Men 15596

    8. Unii-1h7rsq28bj

    9. (r)-6-methyl-n-(1-((1-oxo-3-phenyl-1-(((1-((tetrahydro-2h-pyran-4-yl)methyl)piperidin-4-yl)methyl)amino)propan-2-yl)carbamoyl)cyclopentyl)benzo[b]thiophene-2-carboxamide

    10. Ibodutant [who-dd]

    11. Schembl464393

    12. Chembl266125

    13. Gtpl2117

    14. C37h48n4o4s

    15. Dtxsid20966639

    16. Bdbm50476750

    17. Db12042

    18. 6-methylbenzo(b)thiophene-2-carboxylic Acid (1-(2-phenyl-((1-(tetrahydropyran-4-ylmethyl)piperidin-4-ylmethyl)carbamoyl)ethylcarbamoyl)cyclophenyl)amide

    19. Hy-14770

    20. Cs-0003551

    21. Q5984345

    22. 6-methyl-n-(1-(((2r)-1-((1-(oxan-4-ylmethyl)piperidin-4- Yl)methylamino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)cyclopentyl)-1-benzothiophene-2-carboxamide

    23. Benzo(b)thiophene-2-carboxamide, 6-methyl-n-(1-((((1r)-2-oxo-1-(phenylmethyl)-2-(((1-((tetrahydro-2h-pyran-4-yl)methyl)-4-piperidinyl)methyl)amino)ethyl)amino)carbonyl)cyclopentyl)-

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 644.9 g/mol
    Molecular Formula C37H48N4O4S
    XLogP36
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count11
    Exact Mass644.33962720 g/mol
    Monoisotopic Mass644.33962720 g/mol
    Topological Polar Surface Area128 Ų
    Heavy Atom Count46
    Formal Charge0
    Complexity1020
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of diarrhoea-predominant irritable bowel Syndrome

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.